256 related articles for article (PubMed ID: 32134646)
1. Automated De Novo Design in Medicinal Chemistry: Which Types of Chemistry Does a Generative Neural Network Learn?
Grebner C; Matter H; Plowright AT; Hessler G
J Med Chem; 2020 Aug; 63(16):8809-8823. PubMed ID: 32134646
[TBL] [Abstract][Full Text] [Related]
2. Generative Recurrent Networks for De Novo Drug Design.
Gupta A; Müller AT; Huisman BJH; Fuchs JA; Schneider P; Schneider G
Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29095571
[TBL] [Abstract][Full Text] [Related]
3. Has Artificial Intelligence Impacted Drug Discovery?
Patronov A; Papadopoulos K; Engkvist O
Methods Mol Biol; 2022; 2390():153-176. PubMed ID: 34731468
[TBL] [Abstract][Full Text] [Related]
4. Training recurrent neural networks as generative neural networks for molecular structures: how does it impact drug discovery?
D'Souza S; Kv P; Balaji S
Expert Opin Drug Discov; 2022 Oct; 17(10):1071-1079. PubMed ID: 36216812
[TBL] [Abstract][Full Text] [Related]
5.
Grisoni F; Schneider G
Chimia (Aarau); 2019 Dec; 73(12):1006-1011. PubMed ID: 31883552
[TBL] [Abstract][Full Text] [Related]
6. QSAR-assisted-MMPA to expand chemical transformation space for lead optimization.
Fu L; Yang ZY; Yang ZJ; Yin MZ; Lu AP; Chen X; Liu S; Hou TJ; Cao DS
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33418563
[TBL] [Abstract][Full Text] [Related]
7. Convolutional Neural Networks for the Design and Analysis of Non-Fullerene Acceptors.
Peng SP; Zhao Y
J Chem Inf Model; 2019 Dec; 59(12):4993-5001. PubMed ID: 31710212
[TBL] [Abstract][Full Text] [Related]
8. De novo generation of hit-like molecules from gene expression signatures using artificial intelligence.
Méndez-Lucio O; Baillif B; Clevert DA; Rouquié D; Wichard J
Nat Commun; 2020 Jan; 11(1):10. PubMed ID: 31900408
[TBL] [Abstract][Full Text] [Related]
9. Artificial Intelligence in Drug Design.
Hessler G; Baringhaus KH
Molecules; 2018 Oct; 23(10):. PubMed ID: 30279331
[TBL] [Abstract][Full Text] [Related]
10. Reinforced Adversarial Neural Computer for de Novo Molecular Design.
Putin E; Asadulaev A; Ivanenkov Y; Aladinskiy V; Sanchez-Lengeling B; Aspuru-Guzik A; Zhavoronkov A
J Chem Inf Model; 2018 Jun; 58(6):1194-1204. PubMed ID: 29762023
[TBL] [Abstract][Full Text] [Related]
11. From Target to Drug: Generative Modeling for the Multimodal Structure-Based Ligand Design.
Skalic M; Sabbadin D; Sattarov B; Sciabola S; De Fabritiis G
Mol Pharm; 2019 Oct; 16(10):4282-4291. PubMed ID: 31437001
[TBL] [Abstract][Full Text] [Related]
12. Automated De Novo Drug Design: Are We Nearly There Yet?
Schneider G; Clark DE
Angew Chem Int Ed Engl; 2019 Aug; 58(32):10792-10803. PubMed ID: 30730601
[TBL] [Abstract][Full Text] [Related]
13. Graph neural networks for automated de novo drug design.
Xiong J; Xiong Z; Chen K; Jiang H; Zheng M
Drug Discov Today; 2021 Jun; 26(6):1382-1393. PubMed ID: 33609779
[TBL] [Abstract][Full Text] [Related]
14. Generative Deep Learning for Targeted Compound Design.
Sousa T; Correia J; Pereira V; Rocha M
J Chem Inf Model; 2021 Nov; 61(11):5343-5361. PubMed ID: 34699719
[TBL] [Abstract][Full Text] [Related]
15. Scaffold-Constrained Molecular Generation.
Langevin M; Minoux H; Levesque M; Bianciotto M
J Chem Inf Model; 2020 Dec; 60(12):5637-5646. PubMed ID: 33301333
[TBL] [Abstract][Full Text] [Related]
16. Artificial Neural Networks in Computer-Aided Drug Design: An Overview of Recent Advances.
Cheirdaris DG
Adv Exp Med Biol; 2020; 1194():115-125. PubMed ID: 32468528
[TBL] [Abstract][Full Text] [Related]
17. Deep reinforcement learning for de novo drug design.
Popova M; Isayev O; Tropsha A
Sci Adv; 2018 Jul; 4(7):eaap7885. PubMed ID: 30050984
[TBL] [Abstract][Full Text] [Related]
18. Comparison of structure- and ligand-based scoring functions for deep generative models: a GPCR case study.
Thomas M; Smith RT; O'Boyle NM; de Graaf C; Bender A
J Cheminform; 2021 May; 13(1):39. PubMed ID: 33985583
[TBL] [Abstract][Full Text] [Related]
19. Deep Reinforcement Learning for Multiparameter Optimization in
Ståhl N; Falkman G; Karlsson A; Mathiason G; Boström J
J Chem Inf Model; 2019 Jul; 59(7):3166-3176. PubMed ID: 31273995
[TBL] [Abstract][Full Text] [Related]
20. Application of Deep Neural Network Models in Drug Discovery Programs.
Grebner C; Matter H; Kofink D; Wenzel J; Schmidt F; Hessler G
ChemMedChem; 2021 Dec; 16(24):3772-3786. PubMed ID: 34596968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
